Related Experiment Video
Updated: Jul 2, 2026

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Alcohol consumption and heart failure in hypertensive US male physicians
Luc Djoussé1, J Michael Gaziano
1Division of Aging, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. ldjousse@rics.bwh.harvard.edu
Insights
Light to moderate alcohol consumption may lower heart failure risk in hypertensive men. Even higher intake showed a significant reduction in heart failure incidence.
Area of Science:
- Cardiology
- Epidemiology
- Public Health
Background:
- Heavy alcohol consumption is linked to increased blood pressure and alcoholic cardiomyopathy.
- The relationship between light to moderate alcohol intake and heart failure (HF) risk in hypertensive individuals is not well understood.
Purpose of the Study:
- To investigate the association between light to moderate alcohol consumption and the risk of incident heart failure (HF) among hypertensive male physicians.
Main Methods:
- A prospective study of 5,153 hypertensive male physicians, free of major cardiovascular or cancer events at baseline.
- Alcohol consumption was self-reported and categorized into four groups: <1, 1-4, 5-7, and >=8 drinks/week.
- Heart failure (HF) cases were identified through follow-up questionnaires and validated using Framingham criteria.
Main Results:
- A total of 478 incident heart failure (HF) cases were recorded during the follow-up period.
- Compared to non-drinkers (<1 drink/week), hazard ratios for HF decreased with increasing alcohol consumption: 0.72 (1-4 drinks/week), 0.72 (5-7 drinks/week), and 0.38 (>=8 drinks/week).
- A significant trend (p < 0.001) indicated a lower risk of HF with higher levels of alcohol consumption, even after adjusting for multiple confounding factors.
Conclusions:
- Light to moderate alcohol consumption appears to be associated with a reduced risk of heart failure (HF) in hypertensive men.
- These findings suggest a potential protective effect of certain levels of alcohol intake on HF development in this specific population.
- Further research may be warranted to confirm these associations and explore underlying mechanisms.
Abstract:
Although alcohol drinking increases blood pressure and heavy drinking has been associated with alcoholic cardiomyopathy, little is known about the association between light to moderate drinking and risk of heart failure (HF) in hypertensive subjects. Thus, the association between light to moderate drinking and incident HF in 5,153 hypertensive male physicians who were free of stroke, myocardial infarction, or major cancers at baseline was prospectively examined. Alcohol consumption was self-reported and classified as <1, 1 to 4, 5 to 7, and >or=8 drinks/week. HF was ascertained using follow-up questionnaires and validated using Framingham criteria. Average age was 58 years, and about 70% of subjects consumed 1 to 7 drinks/week. A total of 478 incident HF cases occurred in this cohort during follow-up. Compared with subjects consuming <1 drink/week, hazard ratios for HF were 0.89 (95% confidence interval [CI] 0.70 to 1.12), 0.72 (95% CI 0.57 to 0.91), and 0.38 (95% CI 0.20 to 0.72) for alcohol consumption of 1 to 4, 5 to 7, and >or=8 drinks/week after adjustment for age, body mass index, smoking, randomization group, use of multivitamins, vegetable consumption, breakfast cereal, exercise, and history of atrial fibrillation, respectively (p for trend <0.001). Similar results were obtained for subjects with HF with and without antecedent myocardial infarction and those without diabetes mellitus. In conclusion, our data suggested that light to moderate alcohol consumption was associated with a lower risk of HF in hypertensive male physicians.
Related Concept Videos
Heart Failure I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Hypertension II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies